# Lacunar Stroke hyperAcute Clinical Utilization of Novel Approach Regimens: Rt-PA vs. DAPT Randomised Clinical Trial

Study · id `cardio:ct-nct07111559` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07111559](<https://clinicaltrials.gov/study/NCT07111559>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07111559

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 500 participants.

## Technical summary

Registry record NCT07111559. Randomized; single masking; primary purpose treatment. Start 2025-08-01 (actual); primary completion 2028-03-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 500 participants (planned count; ClinicalTrials.gov record NCT07111559, source copy `cardio:ctgov-nct07111559-2026-08-04`, retrieved 2026-10-26)
- Started: 2025-08-01 (actual) (ClinicalTrials.gov record NCT07111559, source copy `cardio:ctgov-nct07111559-2026-08-04`, retrieved 2026-10-26)
- Primary completion: 2028-03-31 (anticipated) (ClinicalTrials.gov record NCT07111559, source copy `cardio:ctgov-nct07111559-2026-08-04`, retrieved 2026-10-26)
- Completion: 2029-03-31 (anticipated) (ClinicalTrials.gov record NCT07111559, source copy `cardio:ctgov-nct07111559-2026-08-04`, retrieved 2026-10-26)
- Countries: Japan (ClinicalTrials.gov record NCT07111559, source copy `cardio:ctgov-nct07111559-2026-08-04`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07111559-2026-08-04`, retrieved 2026-10-26)

## The registry's words

- Brief title: Lacunar Stroke hyperAcute Clinical Utilization of Novel Approach Regimens: Rt-PA vs. DAPT Randomised Clinical Trial
- Acronym: LACUNAR-tPA
- Condition: Lacunar Stroke
- Condition: Stroke
- Condition: Ischemic Stroke
- Intervention (Drug): rt-PA
- Intervention (Drug): DAPT
- Lead sponsor: Nippon Medical School
- Lead sponsor class: OTHER
- Collaborator: Japan Research Foundation for Clinical Pharmacology
- Collaborator class: UNKNOWN
- Collaborator: Takeda Science Foundation - Medical Research Grant
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Nippon Medical School (`cardio:org-nippon-medical-school`)

## Provenance

Content hash: ecbba76576a455ac0a5499bef083b4006ee5065147f598d14b824a73f44e741a
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
